Lifang Zhu Selected Research

Lifang Zhu Research Topics

7	Neoplasms (Cancer) 04/2024 - 01/2012
3	Squamous Cell Carcinoma of Head and Neck 01/2019 - 11/2014
2	Keshan disease 01/2023 - 12/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024
1	Autoimmune Diseases (Autoimmune Disease) 04/2024
1	Hematologic Neoplasms (Hematological Malignancy) 04/2024
1	Multiple Sclerosis 04/2024
1	Inflammation (Inflammations) 01/2023
1	Periodontitis 01/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Lymphoma (Lymphomas) 09/2022
1	Multiple Myeloma 09/2022
1	Leukemia 09/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Breast Neoplasms (Breast Cancer) 08/2021
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Necrosis 04/2015
1	Hypoxia (Hypoxemia) 03/2015
1	Carcinoma (Carcinomatosis) 08/2014
1	Esophageal Squamous Cell Carcinoma 08/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2012

2	Chimeric Antigen ReceptorsIBA 04/2024 - 09/2022
2	SeleniumIBA 01/2023 - 12/2021
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2014
2	Messenger RNA (mRNA)IBA 04/2015 - 11/2014
1	rheinIBA 01/2023
1	Guanosine Diphosphate (GDP)IBA 01/2023
1	Antimalarials (Antimalarial Agents)IBA 01/2022
1	artemisinin (artemisinine)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	CholesterolIBA 08/2021
1	CollagenIBA 01/2019
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2019
1	osimertinibIBA 01/2019
1	Ephrin-B1 (Ephrin B1)IBA 04/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015
1	CateninsIBA 11/2014
1	CurcuminIBA 11/2014
1	PhytochemicalsIBA 11/2014
1	Antineoplastic Agents (Antineoplastics)IBA 08/2014
1	phenazine FDA Link 01/2012
1	diphenylhydantoic acidIBA 01/2012
1	DiphenylamineIBA 01/2012